CVRx, Inc. is a commercial-stage medical device company focused on neuromodulation solutions for patients with cardiovascular diseases. Its lead product, Barostim, is a pacemker-like device that improves symptoms for patients who have suffered heart failure. CVRx was incorporated in 2000 and is headquartered in Minneapolis, MN.
Name / Ticker | Price | Zen Rating |
---|---|---|
$22.44 | A | |
$28.44 | A | |
$297.55 | A |